Clinical reagent recalled due to temperature and time excursion
Biomerieux Inc is recalling VITEK MS CLINICAL REAGENT VITEK MS-CHCA due to temperature and time excursions that may prevent product performance guarantees. No illnesses reported.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a Class II FDA recall due to temperature and time excursions affecting clinical reagent performance—a risk-of-harm product. No illnesses or injuries have been reported, meeting the criterion for severity score 3 per the rubric.
Plain-English summary
Biomerieux Inc is recalling VITEK MS CLINICAL REAGENT VITEK MS-CHCA (Catalog 411071). The recall affects 46 units with batch numbers 1009391190, 1009434380, and 1009472100, distributed nationwide in the United States.
The recall was initiated because temperature and time conditions exceeded acceptable ranges. As a result, product performance cannot be guaranteed. Healthcare facilities and laboratories that have received affected batches should contact the manufacturer. No illnesses or injuries related to this recall have been reported.
The recalled product
- Product
- VITEK MS CLINICAL REAGENT VITEK MS-CHCA, CATALOG 411071
- Manufacturer
- Biomerieux Inc
- Affected units
- 46
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- UDI/DI 03573026362836
- Batch Numbers: 1009391190
- 1009434380
- 1009472100
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 94 recalled by Biomerieux Inc under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 94 products in this recall →Related recalls
Same manufacturer · Biomerieux Inc
See all →- HighVITEK 2 AST-N447 Test Kit Potentially Returns False Resistant Results
FDA (Devices) · 2026-07-15
- HighSusceptibility test cards recalled over false resistant antibiotic results
FDA (Devices) · 2026-02-11
- HighAntimicrobial susceptibility test cards recalled over false colistin resistance results
FDA (Devices) · 2025-10-08
- SevereVITEK 2 AST Test Kits: Ceftriaxone Concentration Error Risk
FDA (Devices) · 2024-05-01
- HighMedical Device Middleware: MYLA Software Fails to Apply AST Filter Rules
FDA (Devices) · 2023-03-08
Same hazard · temperature excursion
See all →- ModerateCyclophosphamide injection vials recalled after a transportation temperature excursion
FDA (Drugs) · 2025-09-24
- ModerateXolair 75 mg syringes exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateRecombinate antihemophilic factor vials exposed to temperatures outside labeled storage
FDA (Drugs) · 2025-08-13
- ModerateXolair auto-injectors exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30